WallStSmart
ELDN

Eledon Pharmaceuticals Inc

NASDAQ: ELDN · HEALTHCARE · BIOTECHNOLOGY

$3.64
+8.98% today

Updated 2026-04-30

Market cap
$275.92M
P/E ratio
P/S ratio
EPS (TTM)
$-0.52
Dividend yield
52W range
$1 – $5
Volume
1.5M

Eledon Pharmaceuticals Inc (ELDN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+45.1%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+89.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-6.0%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-8.0%
2025-11-14
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-19$-0.10+53.0%$3.00$2.88-4.0%
2025-11-14$-0.21+13.0%$1.76$1.62-8.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.21$-0.10+53.0%
2025-09-30$-0.24$-0.21+13.0%
2025-06-30$-0.22$-0.13+40.9%
2025-03-31$-0.30$-0.08+73.6%
2024-12-31$-0.33$-0.95-189.4%$384000.00
2024-09-30$-0.31$-0.32-3.2%
2024-06-30$-0.30$-1.06-253.3%$560000.00
2024-03-31$-0.37$-0.34+8.1%
2023-12-31$-0.39$-0.29+25.6%
2023-09-30$-0.46$-0.35+23.9%
2023-06-30$-0.46$-0.40+13.0%
2023-03-31$-0.60$-0.75-25.0%

Frequently asked questions

Has Eledon Pharmaceuticals Inc beaten earnings estimates?
Eledon Pharmaceuticals Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +45.1% over the last 4 quarters.
How does ELDN stock react to earnings?
ELDN stock has moved an average of -6.0% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.